In this study, we revealed that MRPL12 undergoes acetylation at lysine 163 (K163), with significantly reduced levels of K163 acetylation observed in ccRCC tissues, which correlates strongly with poor prognosis. The gene discussed is MRPL12; the disease is nonpapillary renal cell carcinoma.